| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Cidara Therapeutics, Inc. - 8-K, Current Report | 7 | SEC Filings | ||
| 26.04. | Cidara Therapeutics, Inc.: Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024 | 483 | GlobeNewswire (Europe) | SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies... ► Artikel lesen | |
| 25.04. | Cidara buys back rights to flu therapy from J&J for $85m | 9 | Pharmaceutical Technology | ||
| 25.04. | Mundipharma to acquire rezafungin assets from Cidara Therapeutics | 9 | Pharmaceutical Technology | ||
| 24.04. | Cidara stock rallies amid $240M private placement, drug update | 12 | Seeking Alpha | ||
| 24.04. | Cidara regains rights to flu med after Janssen makes good on promise to divest | 7 | FierceBiotech | ||
| 24.04. | Cidara Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 24.04. | Cidara Therapeutics, Inc.: Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline | 82 | GlobeNewswire (Europe) | Transaction provides company with an estimated approximately $128 million in cost savings, including approximately $67 million in clinical development and CMC costs over the next three years and an... ► Artikel lesen | |
| 23.04. | Cidara Therapeutics Inc reports results for the quarter ended in December - Earnings Summary | 8 | Reuters | ||
| 22.04. | Cidara Therapeutics GAAP EPS of -$0.04 beats by $0.06, revenue of $17.6M beats by $6.06M | 2 | Seeking Alpha | ||
| 22.04. | Cidara Therapeutics announces receipt of Nasdaq delinquency notice | 3 | Seeking Alpha | ||
| 22.04. | Cidara Therapeutics, Inc.: Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results | 110 | GlobeNewswire (Europe) | SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate... ► Artikel lesen | |
| 22.04. | Cidara Therapeutics, Inc.: Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice | 255 | GlobeNewswire (Europe) | SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate... ► Artikel lesen | |
| 22.04. | Cidara Therapeutics, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 22.04. | Why Cidara Therapeutics (CDTX) Stock Is Falling | 1 | Benzinga.com | ||
| 22.04. | Cidara Therapeutics to implement a reverse stock split | 10 | Seeking Alpha | ||
| 22.04. | Cidara Therapeutics, Inc.: Cidara Therapeutics Announces Reverse Stock Split | 144 | GlobeNewswire (Europe) | SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate... ► Artikel lesen | |
| 16.04. | Cidara Therapeutics, Inc. - 8-K, Current Report | 7 | SEC Filings | ||
| 05.04. | Cidara Therapeutics, Inc. - 8-K, Current Report | 7 | SEC Filings | ||
| 05.04. | Cidara Therapeutics, Inc.: Cidara Therapeutics Presents Promising New Data on Novel Drug-Fc Conjugate Candidates at the American Association for Cancer Research (AACR) Annual Meeting 2024 | 14 | GlobeNewswire (USA) |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 2.757 |
| NEL | 1.607 |
| APPLE | 1.487 |
| BAYER | 1.436 |
| BYD | 1.433 |
| SUPER MICRO COMPUTER | 1.320 |
| DEUTSCHE BANK | 1.211 |
| TUI | 1.187 |
| NVIDIA | 1.180 |
| PLUG POWER | 1.035 |
| TESLA | 981 |
| DAIMLER TRUCK | 922 |
| MERCEDES-BENZ | 891 |
| RHEINMETALL | 869 |
| RWE | 869 |
| AURUBIS | 789 |
| RENK GROUP | 771 |
| DEUTSCHE LUFTHANSA | 756 |
| VOLKSWAGEN | 742 |
| COMMERZBANK | 740 |
| AMAZON | 725 |
| SIEMENS ENERGY | 675 |
| AIXTRON SE | 651 |
| SIXT SE VZ | 636 |
| BASF | 597 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
